Community-acquired Bacterial Pneumonia
📧 Sign up to get email alerts when something new happens for Community-acquired Bacterial Pneumonia.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2025-03-31FDA Approved: NUZYRA — Supplemental Application (Paratek Pharmaceuticals, Inc.)
FDA approved a supplemental application for NUZYRA (omadacycline) to modify the labeling.
-
FDA label_change · 2019-06-13FDA Approved: NUZYRA — Supplemental Application (Paratek Pharmaceuticals, Inc.)
FDA notice about a supplemental application for Nuzyra (omadacycline) from Paratek Pharmaceuticals to request changes to the product label; …
-
FDA label_change · 2015-08-31FDA Approved: TEFLARO — Supplemental Application (Allergan, Inc.)
FDA entry documenting a supplemental application for TEFLARO (ceftaroline fosamil) submitted by Allergan, Inc. This reflects a labeling or i…
-
FDA label_change · 2007-01-24FDA Approved: TYGACIL — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
FDA approved a supplemental application for TYGACIL (tigecycline) submitted by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc., to up…